Cytomegalovirus colitis and immunotherapy.
van Wijk
C A
CA
Department of Pediatrics, Leiden University Hospital, The Netherlands.
Mearin
M L
ML
van de Sluys Veer
A
A
Hoogerbrugge
P M
PM
Weiland
H T
HT
Vossen
J M
JM
D000293:Adolescent; D000792:Angiography; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D001706:Biopsy; D003092:Colitis / Q000175:diagnosis / Q000473:pathology / Q000821:virology*; D003106:Colon / Q000000981:diagnostic imaging / Q000473:pathology* / Q000648:ultrastructure; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007167:Immunotherapy / Q000009:adverse effects; D017403:In Situ Hybridization; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000150:complications* / Q000628:therapy / Q000821:virology
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D001379:Azathioprine; D011241:Prednisone